Parkinson diseases (PD) is the second most common degenerative disease of the central nervous system. The development of early diagnostic biomarkers may help identify at-risk individuals and allow precocious interventions at the onset of disease and more precise monitoring of therapies that may slow disease progression. Proof of concept studies indicated significant differences in pupil light response between PD patients and healthy controls. The feasibility of using pupillometry for assesment of PD will be examined.
Study Type
OBSERVATIONAL
Enrollment
200
Objective and accurate measurement of pupillary responses to light stimuli
Goldschleger Eye Research Institute, Sheba Medical Center,
Tel Litwinsky, Israel
RECRUITINGPupillometry
Pupil response to light stimuli
Time frame: 1 day
Best corrected visual acuity
Visual Acuity
Time frame: 1day
Color vision
Color vision by Farnsworth/Lanthon D-15 Test
Time frame: 1 day
Humphrey 24-2 perimetry
Visual field will be assessed by Humphrey 24-2 perimetry
Time frame: 1 day
Spcetral Domain Optical Coherence Tomography (SD-OCT)
Optic nerve and retinal structure will be assessed by SD-OCT
Time frame: 1 day
visual evoked potential
Occipital cortex function will be assessed by visual evoked potential (VEP)
Time frame: 1 day
Change from baseline Pupillometry at 1 year
Change from baseline in pupil response to light stimuli at 1 year
Time frame: Single visit: 1 day, 1 year after baseline testing
Change from baseline best corrected visual acuity at 1 year
Change from baseline visual acuity at 1 year
Time frame: Single visit: 1 day, 1 year after baseline testing
Change from baseline color vision at 1 year
Change from baseline color vision by Farnsworth/Lanthon D-15 at 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Single visit: 1 day, 1 year after baseline testing
Change from baseline Humphrey 24-2 at 1 year
Change from baseline Humphrey 24-2 visual field at 1 year
Time frame: Single visit: 1 day, 1 year after baseline testing
Change from baseline SD-OCT at 1 year
Change from baseline optic nerve and retinal structure by SD-OCTat 1 year
Time frame: Single visit: 1 day, 1 year after baseline testing
Change from baseline visual evoked potential at 1 year
Change from baseline occipital cortex function by visual evoked potential testing to at 1 year
Time frame: Single visit: 1 day, 1 year after baseline testing